Forte Biosciences, Inc. Cash Flow Statement

Cash Flow Statement Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2023 Dec2024
Operating Activities
Net Income -23.17M-33.48M-38.93M-48.95M-63.52M
Depreciation and Depletion 0.23M0.26M0.29M0.62M0.01M0.05M0.04M0.01M0.04M
Share-based Compensation 1.06M1.32M4.45M6.87M0.04M0.96M4.21M3.28M3.10M
Gains from Investment Securities 0.16M0.06M0.68M0.51M0.52M0.25M0.37M
Asset Writedowns and Impairment 0.06M
Non-cash Items 2.64M1.36M2.13M
Cash from Operations -21.04M-29.54M-31.13M-34.47M-2.77M-18.42M-16.68M-28.71M-30.75M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.01M0.01M0.02M0.25M-0.16M0.13M0.16M
Amortization of Deferred Charges 0.57M0.59M1.16M1.70M
Depreciation & Amortization (CF) 0.23M0.26M0.29M0.62M0.01M0.05M0.04M0.01M0.04M
Change in Working Capital
Change in Account Payables 0.57M0.59M0.30M1.26M0.98M-0.37M-0.29M0.27M3.02M
Change in Accured Expenses 1.30M1.55M2.95M4.13M0.27M-3.20M-0.21M0.19M0.11M
Other Working Capital Changes 1.07M0.16M0.68M0.94M-0.00M0.26M-1.22M0.85M1.37M
Investing Activities
Capital Expenditures 0.23M0.53M0.66M1.97M0.16M0.09M0.04M
Sales of Property, Plant and Equipment 0.01M0.02M0.44M
Change in Acquisitions & Divestments 35.16M48.09M43.73M68.52M93.47M10.10M
Cash from Investing Activities -24.93M24.57M-27.71M-4.19M-0.16M3.58M0.05M-35.99M
Financing Activities
Other financing activities 0.98M0.59M9.10M0.02M0.29M0.11M0.27M1.12M
Cash from Financing Activities 49.92M2.33M89.26M43.54M4.86M66.67M-0.04M24.68M51.86M
Additional items
Change in Cash 3.95M-2.64M30.42M4.88M1.92M51.83M-16.72M-3.98M-14.88M
Beginning Cash Balance -3.95M8.15M5.51M35.93M5.02M-51.83M16.72M3.98M14.88M
Free Cash Flow -21.27M-30.06M-31.79M-36.44M-2.93M-18.42M-16.68M-28.79M-30.78M
Net Cash Flow 3.95M-2.64M30.42M4.88M1.92M51.83M-16.72M-3.98M-14.88M